PART I : Overview: We are a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Our beta islet, T cell and NK cell programs are allogeneic, meaning they are derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. As a result, we...
Q2 FY2026 — expected 2026-08-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001104659-26-026759 | EDGAR | 100K words |
| 2025-03-19 | 2024-12-31 | 0001558370-25-003299 | EDGAR | — |
| 2024-03-14 | 2023-12-31 | 0001558370-24-003165 | EDGAR | — |
| 2023-03-16 | 2022-12-31 | 0001558370-23-003962 | EDGAR | — |
| 2022-03-17 | 2021-12-31 | 0001558370-22-003867 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001104659-25-110851 | EDGAR | 27K words |
| 2025-08-14 | 2025-06-30 | 0001558370-25-011575 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001558370-25-007885 | EDGAR | — |
| 2024-11-05 | 2024-09-30 | 0001558370-24-014345 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001558370-24-011467 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001558370-24-007469 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001558370-23-018408 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001558370-23-014082 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001558370-23-009262 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001558370-22-017287 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001558370-22-013181 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001558370-22-008860 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001104659-26-035256 | EDGAR | 1K words |
| 2026-03-12 | 0001104659-26-026761 | EDGAR | — |
| 2026-01-23 | 0001104659-26-006236 | EDGAR | — |
| 2026-01-12 | 0001104659-26-002748 | EDGAR | — |
| 2026-01-08 | 0001104659-26-001952 | EDGAR | — |
| 2025-12-29 | 0001104659-25-124836 | EDGAR | — |
| 2025-12-12 | 0001104659-25-120654 | EDGAR | — |
| 2025-12-09 | 0001104659-25-119494 | EDGAR | — |
| 2025-11-13 | 0001104659-25-110862 | EDGAR | — |
| 2025-08-29 | 0001104659-25-085658 | EDGAR | — |
103 total filings indexed. 76 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001850119 |
| Ticker | IPSC |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.centurytx.com |
| Listed | 2021-06-18 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report